Share on StockTwits

Ovascience (NASDAQ:OVAS)‘s stock had its “buy” rating reiterated by Wedbush in a research note issued on Tuesday.

Shares of Ovascience (NASDAQ:OVAS) traded up 1.62% during mid-day trading on Tuesday, hitting $12.52. The stock had a trading volume of 10,584 shares. Ovascience has a 52-week low of $5.509 and a 52-week high of $14.44. The stock’s 50-day moving average is $10.20 and its 200-day moving average is $9.10. The company’s market cap is $295.4 million.

Ovascience (NASDAQ:OVAS) last released its earnings data on Thursday, August 7th. The company reported ($0.42) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.45) by $0.03. Analysts expect that Ovascience will post $-1.83 EPS for the current fiscal year.

OvaScience, Inc, is a life science company developing products to improve the treatment of female infertility based on recent scientific discoveries about the existence of egg precursor cells.

Receive News & Ratings for Ovascience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ovascience and related companies with Analyst Ratings Network's FREE daily email newsletter.